It is clear that the DOT's guidance document needs further refinement to help ensure that automakers are able to bring the safety and mobility benefits of autonomous vehicles into ...
I am hopeful that we can avoid that kind of outcome.
We along with policymakers throughout government and the rest of the intelligence community rely on your agency for grou...
As Senator Murray indicated, it is ironic that we have addressed and modernized the FDA in so many other areas but not i...
Yet that company, that personal care products company, is not required to report to the FDA about adverse events.
Our bill is the product of consultations with a wide range of stakeholders, as Senator Feinstein has mentioned, and it w...
See, I think that is why so many companies actually welcome our bill, because they do not want to harm consumers.
It would also give the agency the power to order companies to recall products found to be dangerous.
I have joined with Senator Feinstein in introducing our bipartisan Personal Care Products Safety Act, which would modern...
I think it underscores why we need a national standard, because if you're going to be selling across State lines, it is ...
If there were, could you discuss the limits of FDA's current authority to take action when they do find adverse reaction...